TCRT icon

Alaunos Therapeutics

154 hedge funds and large institutions have $270M invested in Alaunos Therapeutics in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 46 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

13% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 46

20% less capital invested

Capital invested by funds: $336M → $270M (-$66.8M)

Holders
154
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.98M
Puts
$2.32M
Net Calls
Net Calls Change

Top Buyers

1 +$3.47M
2 +$1.93M
3 +$1.91M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.89M
5
Bank of America
Bank of America
North Carolina
+$1.52M

Top Sellers

1 -$899K
2 -$590K
3 -$507K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$396K
5
UBS Group
UBS Group
Switzerland
-$273K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$312K
52
$281K
53
$274K
54
$274K
55
$269K
56
$250K
57
$245K
58
$218K
59
$209K
60
$202K
61
$188K
62
$173K
63
$168K
64
$167K
65
$163K
66
$163K
67
$163K
68
$161K
69
$157K
70
$155K
71
$154K
72
$142K
73
$133K
74
$125K
75
$122K